Frank Demartin

Title: Frank Demartin: Innovator in Pharmaceutical Processes

Introduction

Frank Demartin is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for synthesizing L-ornithine phenylacetate. His work is characterized by a focus on improving manufacturing efficiency and product purity.

Latest Patents

Frank Demartin holds 1 patent for his innovative processes related to L-ornithine phenylacetate. The patent outlines methods that enhance the production of this compound without the use of silver salts or the formation of intermediate salts, such as benzoate salts. These advancements are crucial for commercial-scale manufacturing, ensuring high yields and low impurities in the final product.

Career Highlights

Demartin is currently associated with Ocera Therapeutics, Inc., where he applies his expertise in pharmaceutical processes. His work has been instrumental in advancing the company's capabilities in drug development and manufacturing.

Collaborations

Throughout his career, Frank has collaborated with esteemed colleagues, including Ludwig Pilsl and Georg Winkler. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Frank Demartin's contributions to the field of pharmaceuticals, particularly through his patent on L-ornithine phenylacetate, highlight his role as an innovator. His work not only enhances manufacturing processes but also contributes to the broader goals of improving drug efficacy and safety.